Conventional chemotherapy or hypomethylating agents for older patients with acute myeloid leukaemia?
about
Imidazoquinoxaline derivative EAPB0503: A promising drug targeting mutant nucleophosmin 1 in acute myeloid leukemia.Oligonucleotide aptamer-drug conjugates for targeted therapy of acute myeloid leukemia.Real life experience with frontline azacitidine in a large series of older adults with acute myeloid leukemia stratified by MRC/LRF score: results from the expanded international E-ALMA series (E-ALMA+).Expression of CDKN1C in the bone marrow of patients with myelodysplastic syndrome and secondary acute myeloid leukemia is associated with poor survival after conventional chemotherapy.
P2860
Conventional chemotherapy or hypomethylating agents for older patients with acute myeloid leukaemia?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Conventional chemotherapy or h ...... with acute myeloid leukaemia?
@en
type
label
Conventional chemotherapy or h ...... with acute myeloid leukaemia?
@en
prefLabel
Conventional chemotherapy or h ...... with acute myeloid leukaemia?
@en
P2860
P356
P1476
Conventional chemotherapy or h ...... with acute myeloid leukaemia?
@en
P2093
Felicetto Ferrara
P2860
P356
10.1002/HON.2046
P577
2013-03-20T00:00:00Z